Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
07/2001
07/25/2001EP1117398A2 A method for treating inflammatory diseases by administering a thrombin inhibitor
07/25/2001EP1117397A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
07/25/2001EP0854861B1 Oxyamino oxime ethers, methods and intermediate products for their production, and agents containing them and used for controlling harmful fungi and pests
07/25/2001EP0828725B1 Process for the recovery of ascorbic acid
07/25/2001EP0820437B1 Hydrazonoacetic acid amides and the use thereof as pesticides
07/25/2001EP0772610B9 Dihydrobenzofuranes
07/25/2001CN1305458A Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
07/25/2001CN1305454A Anthranilic acid derivatives as inhibitors of CGMP phosphodiesterase
07/25/2001CN1305124A Photo sensitive resin composition
07/25/2001CN1304933A Process for preparing gamma-butyrolactone
07/25/2001CN1304795A Catalyst for preparing gamma-butyrolactone by dehydrogenation of 1,4-butanediol and its application
07/25/2001CN1304723A Tanshinone compounds containing dihydrofuran ring structure used for medicine to treat hepatic encephalopathy
07/25/2001CN1068880C N-substituted piperidingl bicyclic benzoate derivatives
07/25/2001CN1068879C Dihydrobenzofuranes
07/24/2001US6265603 For treating human cancer
07/24/2001US6265540 Peptide having specific amino acid sequence which is cleavage site for prostate specific antigen proteolytic activity; antiproliferative agents
07/24/2001US6265436 Substituted 5-biphenyl-3,4-dihydroxy-2(5H)-furanones and method of use therefor
07/24/2001US6265209 Subjecting racemic compound to transesterification with acylating agent in presence of hydrolase to optically resolve compound into optically active diester, then alcoholysis
07/24/2001CA2220703C Pharmaceutical compositions for the treatment of alcohol addiction
07/24/2001CA2177774C Novel piperazine, piperidine and 1,2,5,6-tetrahydropyridine compounds; process_for preparing the same and pharmaceutical compositions containing them
07/19/2001WO2001051479A2 Tricyclic compounds with antiviral activity
07/19/2001WO2001051478A1 Method for the preparation of citalopram
07/19/2001WO2001051477A1 Method for the preparation of 5-cyanophthalide
07/19/2001WO2001051469A1 Piperidine and piperazine derivatives which function as 5-ht2a receptor antagonists
07/19/2001WO2001051456A2 Antibacterial agents
07/19/2001WO2001051448A2 Method of gas phase catalytic oxidation to give maleic acid anhydride
07/19/2001WO2001044172A8 Salicylamides as serine protease and factor xa inhibitors
07/19/2001WO2001005392A3 Method for treating chronic pain using mek inhibitors
07/19/2001WO2000073296A3 3-heteroarylalkyl substituted gaba analogs
07/19/2001WO2000041474A3 Anti-cd3 immunotoxins and therapeutic uses therefor
07/19/2001CA2401374A1 Method for the preparation of citalopram
07/19/2001CA2397575A1 Antibacterial agents
07/19/2001CA2396560A1 Tricyclic compounds and method of treating herpes virus
07/19/2001CA2396007A1 Piperidine and piperazine derivatives
07/18/2001EP1116719A2 3-(1-Hydroxy-pentylidene)-5-nitro-3H-benzofuran-2-one, a process for the preparation thereof and the use thereof
07/18/2001EP1116711A2 2-aminoalkyl-1,4-diaminobenzene derivatives and dye composition containing these compounds
07/18/2001EP1116486A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
07/18/2001EP1115723A2 Pesticidal methoximinomethyloxathiazine
07/18/2001EP1115715A1 Method for producing tetrahydrofuran
07/18/2001EP1115707A1 Benzamide derivatives and ther use as cytokine inhibitors
07/18/2001EP1115701A1 Arylsulfonanilide ureas
07/18/2001EP1115695A1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
07/18/2001EP1115694A1 Substituted n-aliphatic-n-aromatic (tertiary)-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
07/18/2001EP1115693A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
07/18/2001EP1115393A1 Sulfonamide derivatives
07/18/2001EP0850221B1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
07/18/2001EP0823903B1 Heterocyclic diaryl compounds, pharmaceutical and cosmetic compositions containing same, and uses thereof
07/18/2001EP0821707B1 Process for producing polytetramethylene ether glycol diester on aluminium magnesium silicate catalysts
07/18/2001EP0755927B1 Dimethylfurancarboxanilide derivative
07/18/2001EP0636025B1 Compounds useful for treating allergic or inflammatory diseases
07/18/2001CN1304447A Treatment of parasitic diseases by inhibition of cysteine proteases of papain superfamily
07/18/2001CN1304405A Method for producing butyrolactones
07/18/2001CN1304400A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
07/18/2001CN1303849A Synthesis of amidosulfourea containing substituted furan nucleus
07/18/2001CN1303815A Vanadium-phosphorus-oxygen process for synthetic catalyst
07/18/2001CN1068584C Phthalic acid diamide derivatives, agricultural and horicultural insecticides, and method for application of insecticides
07/17/2001US6262280 Shilov-type reactions
07/17/2001US6262278 Reacting water and mixture of stereoisomers of chiral cyclic substrate in the presence of non-racemic chiral catalyst to produce by kinetic resolution stereoisomerically enriched cyclic substrate or stereoisomerically enriched hydrolyzate
07/17/2001US6262272 Reacting furan carboxylic acid derivative with acid chloride or acid anhydride in inert solvent containing acid receptor; adding aromatic amine compound to form pyrrole carboxamide compound
07/17/2001US6262114 Leukotriene B4 antagonist compounds and method for treatment
07/17/2001US6262112 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
07/17/2001US6262110 Farnesyl-protein transferase inhibitors
07/17/2001US6262101 Alpha-pyrrolidine, imidazole and thiophene-substituted styrene derivatives; inhibitors of tumor necrosis factor alpha, nuclear factor kappa b, and phosphodiesterase
07/17/2001US6262095 Use of tricyclic derivatives of 1,4-dihydro-1,4-dioxo-1H-naphthalene, novel compounds obtained and their application in theraphy
07/17/2001US6262090 Aminopyridine-containing thiourea inhibitors of herpes viruses
07/17/2001US6262082 Diaminopyridine-containing thiourea inhibitors of herpes viruses
07/17/2001US6262073 Pharmaceutical methods of use of 5-substituted and 5,5 disubstituted-3,4-dihydroxy-2(5H)-furanones
07/17/2001CA2160961C New tricyclic amide compounds, process for preparing the same and pharmaceutical compositions containing them
07/12/2001WO2001049683A1 Novel heteroaryl derivatives, their preparation and use
07/12/2001WO2001049672A1 Method for the preparation of citalopram
07/12/2001WO2001049671A1 Methods for resolving racemic mixtures of 5-substituted 4-hydroxy-2-furanones
07/12/2001WO2001049664A1 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
07/12/2001WO2001049657A1 2-`3-amino-4-(n-hydroxyamino)-succinylamino-acetamides for use as cd23 formation inhibitors
07/12/2001WO2001049645A1 Method and device for cooling a hot reactor gas, for example in the production of phthalic anhydride
07/12/2001WO2001049275A2 Methods and compositions for mitigating pain using nitrate esters
07/12/2001WO2000078743A3 Preparation and use of gamma-butyrolactones as cross-linking agents
07/12/2001US20010007680 Use of a film coating as taste-masking coating of oral dosage forms
07/12/2001DE10000739A1 New piperidine and piperazine derivatives which are antagonists of certain serotonin receptors, are useful in treatment of, e.g. eating disorders, stroke, anxiety or Parkinson's disease
07/12/2001DE10000584A1 Verfahren zur katalytischen Gasphasenoxidation zu Maleinsäureanhydrid A process for the catalytic gas phase oxidation to maleic anhydride
07/12/2001CA2406816A1 Methods for resolving racemic mixtures of 5-substituted 4-hydroxy-2-furanones
07/12/2001CA2395984A1 Novel heteroaryl derivatives, their preparation and use
07/12/2001CA2395267A1 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
07/12/2001CA2394184A1 Methods and compositions for mitigating pain using nitrate esters
07/11/2001EP1114704A2 Waterproofing/preservative compositions
07/11/2001EP1113794A2 Methods of treating viral disease
07/11/2001EP0948492B1 Process for the preparation of heteroaryl-phenylalanines
07/11/2001EP0735819B1 Cryptophycins
07/11/2001CN1303383A Method for producing phthalic anhydride
07/11/2001CN1303375A Aryl phenyl substituted cyclic ketoenols
07/11/2001CN1303362A Method for producing mixtures of 1,4-butanediol, tetrahydrofuran and & gamma-butyrolactone
07/11/2001CN1303281A Use of compounds for elevation of pyruvate dehydrogenase activity
07/11/2001CN1068322C Process for preparing heterocyclic aldehydes
07/10/2001US6258963 Benzylidene-γ-butyrolactones, process for their preparation and their use as UV absorber
07/10/2001US6258842 Method for the preparation of citalopram
07/10/2001US6258841 Antitumor agents or antiproliferation agents
07/10/2001US6258822 Urokinase inhibitors
07/10/2001US6258816 Anti-allergy anti-inflammatory composition
07/10/2001US6258813 D4 receptor selectivity piperazine derivatives
07/05/2001WO2001047909A1 Method for the preparation of citalopram
07/05/2001WO2001047908A1 Stereospecific hydrolysis of optically active esters